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Abstract
CD4+ T cells are essential players for the control of mycobacterial infections. Several
mycobacterial antigens have been identified for eliciting a relevant CD4+ T cell mediated-
immune response, and numerous studies explored this issue in the context of Mycobacte-
rium tuberculosis infection. Antigen 85 (Ag85), a highly conserved protein across Myco-
bacterium species, is secreted at the early phase of M. tuberculosis infection leading to
the proliferation of Ag85-specific CD4+ T cells. However, in the context of Mycobacterium
avium infection, little is known about the expression of this antigen and the elicited immune
response. In the current work, we investigated if a T cell receptor (TCR) repertoire mostly,
but not exclusively, directed at Ag85 is sufficient to mount a protective immune response
against M. avium. We show that P25 mice, whose majority of T cells express a transgenic
TCR specific for Ag85, control M. avium infection at the same level as wild type (WT) mice
up to 20 weeks post-infection (wpi). During M. avium infection, Ag85 antigen is easily
detected in the liver of 20 wpi mice by immunohistochemistry. In spite of the propensity of
P25 CD4+ T cells to produce higher amounts of interferon-gamma (IFNγ) upon ex vivo
stimulation, no differences in serum IFNγ levels are detected in P25 compared to WT
mice, nor enhanced immunopathology is detected in P25 mice. These results indicate that
a T cell response dominated by Ag85-specific T cells is appropriate to control M. avium
infection with no signs of immunopathology.
Introduction
The immune response to mycobacteria is a very complex process. Though it is known that sev-
eral cell populations play important parts, from neutrophils, to macrophages (Mϕ), dendritic
cells and CD4+ and CD8+ T cells, among others, the precise profile of a protective immune
response against pathogenic mycobacteria is still unclear. CD4+ T cells have been shown to be
absolutely required as they participate in the activation of antigen presenting cells and CD8+ T
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cells. However, the precise antigenic specificity required for an initial and prolonged protec-
tion is still debatable. A few reports showed CD4+ and CD8+ T cell expansions during the
immune response to Mycobacterium tuberculosis [1–5] and these skewed TCR repertoires have
been associated with more severe manifestations of disease [1,4], though a cause or conse-
quence relationship remains to be established.
Several mycobacterial antigens have been shown to elicit a protective immune response
such as ESAT-6, CFP10 or Ag85 [6]. Amongst these, the Ag85, present in three distinct vari-
ants (Ag85A, B or C), is one of the most well described antigens, being highly conserved across
the Mycobacterium genus [7]. Ag85 is associated with the cell wall and is a major secreted pro-
tein [7,8] that has been successfully detected in the sputum of patients with pulmonary tuber-
culosis and in the cerebral spinal fluid of patients with meningitis tuberculosis [9]. In vitro M.
tuberculosis infection of human monocytes and pulmonary Mϕ shown that the gene encoding
for Ag85B, the fbpB, is expressed as soon as 4 h following infection, maintained for up to 5
days post-infection (dpi) [10,11]. In mouse models, Rogerson and colleagues showed that fbpB
is expressed both in the acute and chronic phases of infection, peaking around 20 dpi [12].
More recently, proliferation of adoptively transferred CFSE-labelled Ag85B-specific CD4+ T
cells was shown as soon as 14 days after M. tuberculosis infection [13,14] though this phenotype
is lost when these cells are transferred into mice with over 4 wpi [14]. Altogether, these data
supports the long accepted concept that Ag85 is an early-secreted protein during M. tuberculo-
sis infection.
A specific Ag85 amino acid (aa) sequence, the peptide 25 (P25; aa240-254), has been shown
to be the major mediator of CD4+ T cell cytokine production and proliferation in response to
Ag85 [15]. In line with this, Takatsu and colleagues generated the P25 mouse model, whose T
cells express a Vα5+Vβ11+ transgenic TCR that recognizes Ag85’s P25 in the context of I-Ab
[16]. Upon in vivo M. tuberculosis infection, P25 mice presented an identical bacterial burden
when compared with their WT peers at 4 wpi [17] suggesting that an early immune response
to M. tuberculosis mostly directed to Ag85 is sufficient to control the bacterial burden to levels
similar to the ones in WT mice with a diverse TCR repertoire.
To our knowledge, seldom work has been described on the relevance of Ag85 in the context
of M. avium infection [8,18]. We investigated whether an immune response mostly directed at
Ag85 is able to induce protection against M. avium infection and whether this response is
enough to maintain long term protection. To do so, we have infected the P25 TCR transgenic
mouse model, in a RAG sufficient background, with M. avium and evaluated their immune
response in comparison to WT mice. Additionally, we assessed which T cells were more
responsive to the infection, the Ag85-specific or the non-specific CD4+ T cells. Our results
indicate that a T cell response mostly directed towards Ag85 is appropriate to control M.
avium infection, at both initial and more prolonged phases, with no signs of immunopathol-
ogy, despite the dominance of activated Ag85-specific T cells.
Material and methods
Mice
Breeding couples of WT (C57BL/6J) and TCRαKO mice (B6.129S2-Tcratm1Mom/J) [19] were
purchased from Charles River Laboratories (Barcelona, Spain) and from The Jackson Labora-
tory (Bar Harbor, ME, USA), respectively. Breeding pairs from P25 [C57BL/6-Tg(H2-Kb-
Tcra,-Tcrb)P25Ktk/J] [16] and Limited mice [20] were kindly provided by Dr. Anne O’Garra
(The Francis Crick Institute, London, UK) and by Dr. Diane Mathis and Dr. Christophe Beno-
ist (Division of Immunology, Department of Microbiology and Immunobiology, Harvard
Medical School, Boston MA, USA), respectively. All animals were bred at the local animal
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facility and housed in a biosafety level 2 facility under pathogen-free conditions with sterilized
food, water, bedding and environmental enrichment. Mice were 8 to 12 weeks old at the start
of the experiments, which were performed in accordance with the EU Directive 2010/63/EU
and the Portuguese legislation Decree-law 113/2013, approved by the local Animal Ethics
Committee (Comissão de Ética Animal conjunta IBMC/INEB e ICVS). All personnel involved
in the procedures were approved as competent for animal experimentation by the national
competent authority for animal protection (Direção Geral de Alimentação e Veterinária,
DGAV).
Experimental infection and bacterial quantification
Infection with M. avium strain 2447 (provided by Dr. Franc¸oise Portaels, Institute of Tropical
Medicine, Antwerp, Belgium) was performed intravenously through the lateral tail vein, deliv-
ering 106 colony forming units (CFU) per mouse, in a 200 μL volume of sterile saline with
0.05% of Tween80. At selected time-points post-infection, mice were euthanized by carbon
dioxide inhalation; organs were aseptically removed and individually homogenized in sterile
water with 0.05% of Tween80. Ten-fold serial dilutions of organ homogenates were plated
onto OADC-supplemented Middlebrook 7H10 agar plates (Becton Dickinson, NJ, USA) and
incubated at 37 ˚C for 7 days before bacterial burden determination.
Spleen single-cell suspension preparation, ex vivo stimulation and IFNγ
quantification by ELISA
Spleen single-cell suspensions were prepared by gentle disruption of the organs between two
notched slide glasses. Erythrocytes were lysed using a hemolytic solution (155 mM NH4Cl, 10
mM KHCO3, 0.1 mM Na2EDTA, pH 7.2). After washing, cells were resuspended in supple-
mented RPMI 1640 (10% heat-inactivated fetal bovine serum, 10 mM HEPES, 1 mM sodium
pyruvate, 2 mM L-glutamine, 50 mg/mL streptomycin and 50 U/mL penicillin, all from
Merck, NJ, USA) and enumerated using a hemocytometer and 4% trypan blue.
For ex vivo stimulation, 5×105 splenocytes were plated per well in a 96-well plate and incu-
bated, in triplicate, in the presence of 4 μg/mL of Ag85240–254 peptide (M. avium sequence:
FQDAYNGAGGHNAVF; Metabion, Germany). Incubation in the presence of 4 μg/mL of
concanavalin A (ConcA) or in the absence of stimuli was used as positive and negative con-
trols, respectively. Supernatants were collected 72 h after culture in a 37 ˚C, 5% CO2 incubator
and IFNγ concentration was determined by ELISA [R4-6A2 and AN18 were used as capture
and detection antibodies, respectively (eBioscience, O¨sterreich, Austria)].
In vitro T cell protection assay
Bone marrow (BM) derived Mϕ (BM-Mϕ) from WT mice were prepared from single-cell sus-
pensions of BM cells aseptically flushed from femurs using a 25 G needle and syringe loaded
with ice-cold supplemented RPMI (without penicillin and streptomycin). Cells were supple-
mented with murine Mϕ colony-stimulating factor (M-CSF; Peprotech, NJ, USA) to a final
concentration of 20 ng/mL, and 5×104 cells were plated per well of a 96-well plate. Cells were
placed in the incubator at 37 ˚C and 5% CO2; 4 days later, 20 μL of M-CSF at 20 ng/mL was
added per well. At day 7 of differentiation, media was replaced by 40 μL of M. avium inoculum
at 2.5×106 CFUs/mL and cells incubated for 4 h. Afterwards, BM-Mϕ were thoroughly washed
with warm Hank’s Balanced Salt Solution (HBSS, Merck, NJ, USA) and left in supplemented
RPMI (without penicillin and streptomycin) in the incubator. One day after infection, 1×105,
5×104 or 2.5×104 purified CD4+ T cells from each mouse were added to the M. avium-infected
BM-DMϕ. Briefly, CD4+ T cells were obtained from spleen single-cell suspensions (as
P25 mice control M. avium infection
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described above) upon purification by negative separation using the CD4+ T Cell Isolation Kit
and an autoMACS separator (both from Miltenyi Biotec, Germany), accordingly to the manu-
facturer’s instructions; a purity of 91±6% was achieved. All conditions were performed in
triplicate; a set of wells was left with infected BM-DMϕ and without T cells. Viable bacteria
quantification was performed 3 days later upon cells’ disruption with sterile H2O with 0.05%
Tween80 and 0.5% saponin. Bacterial burden was also assessed in triplicate wells with purified
T cells only (1×105 T cells; no BM-DMϕ) representing less than 1% of the bacterial load of the
respective T cells co-cultured with infected BM-Mϕ.
Cell staining and flow cytometry
Cell surface staining was performed using specific antibody combinations directed to mouse
CD3 (145-2C11), CD4 (RM4-5), CD8 (53–6.7), CD44 (IM7), CD62L (MEL-14), Vα2 (B20.1),
Vα3.2b/c (RR3-16), Vα8.3 (B21.14), Vα11.1/.2 (RR8-1), Vβ5 (MR9-4) and/or Vβ11 (KT11; all
purchased from BioLegend, CA, USA). Staining was performed on ice for 20 min using FACS
buffer (PBS with 0.3% BSA, 0.01% sodium azide and 2 mM Na2EDTA).
For the tetramer stain, Ag85240–254-loaded I-Ab tetramer (M. tuberculosis peptide sequence:
FQDAYNAAGGHNAVF; National Institute of Health Tetramer Core Facility, Emory Univer-
sity Vaccine Center, Atlanta, GA) was used and staining was performed for 1 h at 37 ˚C. Cells
were thoroughly washed and stained with the surface antibody mix as described above.
For intracellular cytokine staining, 2×106 cells were incubated with 16 μg/mL M. avium
Ag85240–254 peptide or with a combination of 0.05 μg/mL Phorbol myristate acetate (PMA)
and 0.5 μg/mL ionomycin, as a positive control. All conditions, including the non-stimulated
control, were performed in the presence of recombinant murine interleukin 2 (IL2) at 100 U/
mL. After 1 h of incubation (37 ˚C, 5% CO2), brefeldin was added to a final concentration of
10 μg/mL. Cells were further incubated for 5 h, upon which were washed and surface stained
with antibodies directed to mouse CD3, CD4, CD8, Vβ11, Vα2, Vα3.2b, Vα8.3 and Vα11.1/2
(same clones as above). Cells were fixed and permeabilized with 2% paraformaldehyde and
FACS buffer supplemented with 0.5% saponin, respectively, and intracellularly stained using
antibodies directed to mouse IFNγ (XMG1.2), IL2 (JES6-5H4) and tumor necrosis factor
(TNF; MP6-XT22; all from BioLegend).
Cells were acquired on a 12-color LSRII flow cytometer using FACSDiva software (Becton
Dickinson, Franklin Lakes, NJ); data analysis was performed using FlowJo software (Tree Star,
Ashland, OR). Gating strategies are represented in S1 Fig.
Immunohistochemistry, immunofluorescence and liver histology
Detection of Ag85 and inducible nitric oxide synthase (iNOS) in tissues was performed by
immunohistochemistry and immunofluorescence, respectively, in paraformaldehyde-fixed,
paraffin-embedded tissues. Liver sections were briefly placed at 70 ˚C for paraffin melting and
then rehydrated. Antigen retrieval was completed upon slide incubation with citrate buffer
(pH 6; Sigma-Aldrich, Germany) at 96 ˚C, in a water bath, for 30 min followed by 20 min at
room temperature. For iNOS, non-specific binding was blocked using 3% BSA in PBS with
0.05% Tween20 for 2 h at room temperature. Tissues were incubated overnight, at 4 ˚C, with a
purified rabbit anti-mouse iNOS antibody (clone M-19; Santa Cruz Biotechnology, CA, USA).
Detection was achieved using a goat anti-rabbit Alexa Fluor 488 (ThermoFisher Scientific, IL,
USA) and nuclei were stained using Vectashield with 1 ug/mL of DAPI (Vector Labs, CA,
USA). No significant signal is detected in liver sections from iNOS KO mice (data not shown).
Quantification of iNOS+ lesions was performed from one liver section per mouse; five random
fields were photographed under the 20× objective, one operator performed lesion classification
P25 mice control M. avium infection
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blindly and the percentage of iNOS+ lesions was calculated per mouse. Ag85 staining was per-
formed using the ImmPRESS™ Excel Amplified HRP Polymer Staining Kit (Vector Labs, CA,
USA) following manufactures’ instructions, and the rabbit polyclonal antibody to M. tubercu-
losis Ag85B (Abcam, UK), which was incubated for 1 h at room temperature. No significant
signal is detected in liver sections from non-infected mice or from mice infected with an
Ag85KO-M. tuberculosis strain (data not shown). Upon Ag85 stain, bacilli were detected using
the standard Ziehl-Neelsen procedure.
Determinations of lesion type (well-organized granulomas, poorly-organized granulomas
and inflammatory infiltrates) in the liver were performed in hematoxylin and eosin stained
sections. From one liver section per mouse, five random fields were photographed under the
20× objective, and lesion classification was performed blindly by two independent operators.
The percentage of each lesion type was calculated per mouse.
All slides were visualized using a BX61 microscope with an Olympus DP70 camera. Image
and area analysis was performed using Image J software (National Institutes of Health, MD,
USA).
Statistical analysis
Prism software (GraphPad v.7.a) was used for all the statistical analysis. Shapiro-Wilk normal-
ity test was used to assess the normal distribution of the data. As all data followed a normal dis-
tribution, parametric tests were performed: Student t-test to compare two groups; one-way
analysis of variance (ANOVA) test, followed by Bonferroni post-hoc tests, to compare three or
more groups; and two-way ANOVA, followed by Bonferroni post-hoc tests, to address strain
and time of infection contribution to the evaluated variables. Differences were considered sta-
tistically significant for p-value<0.05. In the depicted graphs, symbols represent a single
mouse and the horizontal line the mean, except in Fig 1B where each symbol represents the
average of the group and the error bars the standard deviation. For some variables and in some
instances, fold-variation was calculated as the average of the ratio of the non-infected mice
(average of the group) over infected mice (each mouse individually).
Results
M. avium growth is controlled in P25 mice to levels similar to WT mice at
early and late phases of the infection
Ag85240-254 from M. tuberculosis and M. avium differ in a single aa (A246G) located at one of
the five peptide’s TCR recognition sites [21]. To determine the ability of P25 transgenic T cells
to recognize M. avium-infected cells, an in vitro experiment was performed. When co-cultured
with M. avium-infected BM-Mϕ, purified CD4+ T cells from 4 week M. avium-infected P25
mice control bacterial growth to similar levels when compared to WT CD4+ T cells (Fig 1A).
Reduced protection conferred by P25 CD4+ T cells in comparison to WT is only detected
when a very low number of CD4+ T cells are used (2.5×104 T cells/well; which corresponds to
a ratio of BM-Mϕ to T cells of 2:1; Fig 1A). Upon in vivo infection, P25 and WT mice present
similar bacterial burden up to 20 wpi; TCRα KO mice (deprived from αβ T cells) and Limited
mice (an alternative TCR transgenic model with diversity restricted at the CDR3 of the TCRα
chain [20]) were used confirming that mice with no T cells, or with non-specific T cells,
respectively, are unable to halt M. avium growth (Fig 1B and S2 Fig).
The ability of P25 mice to confer protection to similar levels as WT mice, up to 20 wpi, was
surprising taking into consideration that Ag85 has been described as an early secreted antigen
during M. tuberculosis infection [12,14]. However, in animals infected with M. avium, Ag85 is
P25 mice control M. avium infection
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Fig 1. P25 mice control M. avium growth to the same extent as WT mice. A) CFU quantification on infected Mϕ, co-cultured with decreasing numbers CD4+ T cells
isolated from WT or P25 mice at 4 wpi.  p<0.05, p<0.005 and p<0.001 by one-way ANOVA test followed by Bonferroni post-hoc tests for the comparison of all
groups to infected Mϕ, as a control; Student t-tests were performed for comparisons between the same amount of WT and P25 CD4+ T cells and represented by # for
p<0.05. Depicted is one out of two independent experiments. B) Spleen (left) and liver (right) CFUs of WT, P25 and TCRα KO mice. Comparisons were performed by a
two-way ANOVA test followed by Bonferroni post-hoc tests and differences marked with  are for comparisons of P25 vs. TCRα KO and with # for WT vs. TCRα KO;
no significant differences are detected for the comparison of P25 vs. WT.  or # p<0.05,  or ## p<0.005 and  or ### p<0.001. Depicted is one (with 4 to 9 mice per
group) out of two independent experiments. C) Representative liver sections stained for Ag58 (brown) of 16 and 20 wpi mice. Bacilli were detected by Ziehl-Neelsen
staining (red). Scale bar, 10 μm.
https://doi.org/10.1371/journal.pone.0193596.g001
P25 mice control M. avium infection
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clearly detected, by immunohistochemistry, in the liver of WT, P25 and TCRα KO mice at late
periods of infection (16 and 20 wpi; Fig 1C) revealing a continuous production of this protein
by M. avium during chronic infection. Ag85 is detected within most, though not all, infected
cells (Fig 1C, black and red insets, respectively).
Since IFNγ production by CD4+ T cells is a key element in the protective immune response
to M. avium [22,23] the kinetics of CD4+ T cell expansion and IFNγ production were analysed.
Four weeks upon M. avium infection, no differences are detected in the serum IFNγ levels and
numbers of splenic CD4+ T cells between P25 and WT mice (Fig 2A and 2B). Regarding the
activation phenotype of the CD4+ T cell compartment, non-infected P25 mice show higher
percentages of naive (CD62L+CD44lo/int) and central memory (CD62L+CD44int/hi) cells, and
lower percentages of activated (CD62L-CD44int/hi) cells in comparison to non-infected WT
mice (Fig 2C). These differences between WT and P25 CD4+ T cell profiles are preserved or
even exacerbated upon infection. In fact, infection leads to more pronounced fold-decrease of
Fig 2. P25 T cells expand and produce protective cytokines throughout M. avium infection. A) IFNγ quantification in the serum from non-infected (Ninf) and from 4
wpi WT and P25 mice. B) Enumeration of splenic CD4+ T cells. C) Percentage of naive (CD62L+CD44lo/int; left), activated (CD62L-CD44int/hi; middle) and central
memory (CD62L+CD44int/hi; right) cells among splenic CD4+ T cells. D) IFNγ quantification in splenocytes’ supernatant upon ex vivo stimulation with M. avium
Ag85B240-254 peptide. E) Percentage of spleen IFNγ (left), IL2 (middle) and TNF
+ cells among splenic CD4+ T cells upon stimulation with M. avium Ag85B240-254 peptide.
F) Mean fluorescence intensity of IFNγ (left), IL2 (middle) or TNF (left). p< 0.05, p< 0.005 and p< 0.001 by two-way ANOVA followed by Bonferroni post-hoc
tests (A to E) or by Student t-test (F). One out of two independent experiments is depicted.
https://doi.org/10.1371/journal.pone.0193596.g002
P25 mice control M. avium infection
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naïve T cells in WT mice than in P25 (fold-change of infected to non-infected of 0.56±0.07 vs.
0.82±0.05; p<0.0001 by Student t-test; Fig 2C).
Upon ex vivo stimulation with Ag85240-254, splenocytes from infected P25 mice produce
3.5-fold more IFNγ than the ones from WT mice (Fig 2D). In addition, the percentage of
CD4+ T cells producing IL2 or TNF is also higher in P25 in comparison to WT mice (Fig 2E).
When testing 4 wpi mice, the percentage of CD4+ T cells producing IFNγ is similar for WT
and P25 mice, though P25 splenocytes present higher percentages of CD4+ T cells producing
IL2 or TNF (Fig 2E). Notwithstanding infected WT and P25 mice have similar percentages of
CD4+ T cells producing IFNγ, P25 CD4+ T cells produce more IFNγ than their WT peers, as
assessed by the mean fluorescence intensity (MFI; Fig 2F). No differences are detected between
both mouse strains for CD4+ T cells’ IL2 and TNF MFI. Altogether, these data show that P25
mice control infection similarly to WT, although with a distinct CD4+ T cell activation and
cytokine producing profile. The higher production of pro-inflammatory cytokines in P25 mice
lead us to question if a potentially excessive immune response would take place leading to
immunopathology.
M. avium-infected P25 mice present no signs of increased
immunopathology in comparison to WT mice
As splenocytes from infected P25 mice are more prone to produce IFNγ and TNF compared
to WT, we questioned if control of bacterial growth in P25 mice was accompanied by increased
immunopathology. Excessive leukocyte infiltration and altered granuloma profile have been
shown in mouse models of excessive immune response [24–26]. The total area with inflamma-
tory infiltrates and the average lesion size were measured in WT, P25 and TCRα KO mice at
16 wpi. No differences are detected for both measurements (Fig 3A and 3B). Additionally,
lesions’ structure was categorized as inflammatory infiltrates, well- or poorly-organized granu-
lomas [27]; P25 and WT mice present no differences in between them and both differ signifi-
cantly from infected TCRα KO mice, which are practically deprived of well-organized
granulomas (Fig 3C and 3E top).
Cytokine production, particularly IFNγ and TNF, are key for Mϕ activation and the initia-
tion of bactericidal mechanisms, such as the one mediated by the iNOS [22,28–31]. Although
iNOS KO mice are significantly more efficient in clearing M. avium infection in comparison
to WT mice [32] this enzyme is still a suitable marker for Mϕ activation during M. avium
infection. A similar percentage of iNOS+ lesions are present in WT and P25 mice and, once
again, both groups differ significantly from TCRα KO mice, which present a smaller frequency
of iNOS+ lesions (Fig 3D and 3E bottom). Altogether, these data suggest no increased immu-
nopathology in infected P25 mice in comparison to WT mice.
TCR transgenic CD4+ T cells are the ones preferentially activated during
the immune response to M. avium in P25 mice
The P25 mice used in this study are in a RAG-sufficient background, enabling the differentia-
tion of a minor T cell population expressing non-transgenic TCRs. For that reason, these mice
have cells specific for antigens other than Ag85240-254. We investigated to what extent the
CD4+ T cells non-specific for Ag85240-254 would play a relevant role on the immune response
of P25 mice to M. avium infection. Ag85240-254-loaded I-Ab tetramers were used to identify the
Ag85240-254-specific CD4
+ T cells, revealing that this T cell population is very scarce in non-
infected WT mice and very abundant in P25 mice (over 85%; Fig 4A). The number of these
Ag85-specific CD4+ T cells expands during infection in both mouse strains (Fig 4B). Because
the tetramer staining protocol coupled to ex vivo stimulation and intracellular staining
P25 mice control M. avium infection
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protocol is technically problematic, specific antibodies for the TCR chains were used. The P25
transgenic TCR is composed by a Vα5 and a Vβ11 TCR chains; as there are no specific anti-
bodies for the TCR Vα5 chain, identification of the transgenic TCR was done using anti-Vβ11
plus a mixture containing all the commercially available antibodies directed to other TCR Vα
chains (VαMix, i.e. the Vα2, 3.2, 8.3, 11.1 and 11.2 chains). P25 transgenic cells were defined as
VαMix
-Vβ11+, and the non-transgenic defined as all the CD4+ T cells that are not VαMix
-Vβ11+
(S1A Fig). P25 transgenic cells constitute around 85% of the CD4+ T cells (S3A Fig) and the
vast majority of those cells stain with Ag85240-254-tetramers (S3B and S3C Fig). A small
Fig 3. No signs of immunopathology are detected in M. avium chronic infected P25 mice. A) Assessment of the total lesioned area. B) Quantification of the
average lesion size. C) Classification and percentage of each lesion type. D) Percentage of liver iNOS+ lesions. p< 0.05, p< 0.005 and p< 0.001 by one-way
ANOVA test followed by Bonferroni post-hoc tests. A pool from three independent experiments is depicted. E) Representative histological liver sections stained by
hematoxylin and eosin (top) or stained for iNOS (bottom); in the later, iNOS+ lesions (agglomerates of DAPI+ nuclei accompanied by iNOS stain; filled outlines) and
iNOS- lesions (agglomerates of DAPI+ nuclei without iNOS stain; dashed outlines) are depicted. All assessments were performed on liver sections of WT, P25 and
TCRα KO mice at 16 wpi. Scale bar, 100 μm.
https://doi.org/10.1371/journal.pone.0193596.g003
P25 mice control M. avium infection
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percentage of VαMix
+Vβ11+ CD4+ T cells also binds the Ag85240-254 tetramer however this
population represents only a minor population of the total CD4+ T cells (0.45±0.04%; S3B
Fig). These data indicate that the use of the Vβ11 antibody together with the VαMix antibodies
enables the identification of most of the Ag85-specific cells.
Fig 4. Upon M. avium infection of P25 mice, TCR transgenic CD4+ T cells are preferably more activated then their non-
transgenic peers. A) Representative FACS plot of Ag85B240-254-tetramer
+ cells gated on CD4+ T cells. B) Enumeration of Ag85B240-
254-tetramer
+ CD4+ T cells in the spleen of non-infected (Ninf) and of 4 wpi WT and P25 mice. C) Percentage of naive
(CD62L+CD44lo/int; left), activated (CD62L-CD44int/hi; middle) and central memory (CD62L+CD44int/hi; right) cells which are TCR
transgenic (Tg; identified as VαMix
-Vβ11+) or non-transgenic (Non-Tg; identified as all that are not VαMix
-Vβ11+) among CD4+ T
cells from spleens from non-infected or from 4wpi P25 mice. D) Percentage of IFNγ+ (left), IL2+ (middle) and TNF+ cells (left) upon
ex vivo stimulation with M. avium Ag85B240-254, among P25 transgenic or non-transgenic CD4+ T cells. E) Mean fluorescence
intensity of IFNγ (left), IL2 (middle) and TNF (left), among cytokine-positive transgenic or non-transgenic CD4+ T cells. p< 0.05,
p< 0.005 and p< 0.001 by two-way ANOVA followed by Bonferroni post-hoc tests (B to D) or by Student t-test (E). One out
of three independent experiments is depicted.
https://doi.org/10.1371/journal.pone.0193596.g004
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Similar to the total CD4+ T cell compartment within P25 mice upon infection, the percent-
age of naive P25 transgenic CD4+ T cells decreases (Fig 4C left), while the activated population
increases (Fig 4C middle). Although some non-transgenic CD4+ T cells also acquire an acti-
vated phenotype upon infection, the fold-change is higher in the P25 transgenic cells in com-
parison to the non-transgenic (2.05±0.21 vs. 1.48±0.34, p<0.0001 by Student t-test). Regarding
cytokine production, infected P25 transgenic CD4+ T cells are enriched with IFNγ+ and TNF+
CD4+ T cells when compared with non-infected peers (Fig 4D). Despite non-transgenic cells
become also enriched with IFNγ+ cells upon infection, a higher percentage of P25 transgenic
than non-transgenic CD4+ T cells producing cytokines is detected (Fig 4D). Additionally, P25
transgenic cells also present higher IFNγ MFIs than non-transgenic CD4+ T cells, though the
last have higher TNF and IL2 MFIs (Fig 4E).
Discussion
In this study, we used P25 mice in a RAG-sufficient background to investigate the immune
response to M. avium mediated by a repertoire clearly, but not exclusively, dominated by
Ag85-specific T cells. We show that an immunodominant T cell response to Ag85 controls the
bacterial burden to the same level as a WT diverse T cell repertoire. Although upon infection
P25 mice present a greater increase in the proportion of activated CD4+ T cells, there are no
signs of in vivo higher production of IFNγ or of immunopathology in comparison to WT
mice. Curiously, when stimulated ex vivo, cells from P25 mice produce more IFNγ, IL2 and
TNF. Although P25 mice harbour non-transgenic CD4+ T cells, activation and immune
response is clearly dominated by the P25 TCR transgenic CD4+ T cells.
Data available on the Ag85-directed immune response in the context of M. tuberculosis
infection advocate this peptide as an early-secreted antigen, as its expression peaks around 20
dpi and because Ag85-specific CD4+ T cells fail to proliferate when transferred to M. tuberculo-
sis infected mice with over 4 weeks of infection. To our knowledge, only one report is available
describing the bacterial burden of P25 mice infected by M. tuberculosis; this evaluation was
performed at 4 wpi and no information exists for longer periods of infection [17]. Here we
show that in the M. avium infection model, protection conferred by P25 transgenic T cells
is sustained throughout the 20 weeks of infection evaluated. The fact that we observe in the
P25 mouse model a TCR repertoire sufficient to sustain an immune response to M. avium
might be related to the fact that splenocytes from M. avium infected mice, when stimulated
with antigenic fractions from culture filtrate, envelope or cytosol, produce the highest
levels of INFγ in response to the Ag85-containing fractions [8]. These data suggest that the
immune response to Ag85 might be preponderant for the control of the M. avium bacterial
growth.
A recent report by Moguche and colleagues has shown that in the context of M.
tuberculosis infection, the immune response to Ag85 was arrested due to the reduced antigen
availability during persistent infection; these Ag85-specific CD4+ T cells contracted in number
and exhibited a less differentiated phenotype (similar to memory cells) with the ability to pro-
duce multiple cytokines [14]. Our data suggests that the immune response in M. avium-
infected P25 mice is supported by the continuous expression of Ag85 by the bacilli, as we
are able to clearly detect Ag85-staining in most M. avium infected cells from 20 wpi mice.
Nevertheless, we did not investigate whether the expression of this antigen is altered from
the acute to the chronic phase of the M. avium infection, as described for M. tuberculosis
[12].
We observe a similar fold-increase for both IFNγ serum levels and CD4+ T cells numbers in
both WT and P25 infected mice when compared with their non-infected peers (15.56±5.60 vs.
P25 mice control M. avium infection
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17.74±6.12, p-value = 0.5078; 3.24±0.91 vs. 3.73±1.42, p-value = 0.4524, respectively. Student t-
tests were performed). These results are quite interesting since infected WT and P25 differ sig-
nificantly in the frequency of activated CD4+ T cells present during infection, even though
progressing similarly when compared with their non-infected peers. We hypothesize that
infection does not generate sufficient Ag85 protein levels to stimulate all P25 CD4+ T cells to
their full potential. Supporting this idea is the observed massive IFNγ levels seen after ex vivo
stimulation of splenocytes from infected P25 mice with M. avium-Ag85240-254 peptide
(3.5-fold more IFNγ is produced by infected P25 mice in comparison to WT), a condition
where more cognate-antigen is available. In line with this, and despite the percentage of IFNγ-
producing CD4+ T cells in P25 and WT mice being similar, these cells have higher IFNγ MFI
than the ones from WT mice, which may also suggest an enhanced IFNγ-producing pheno-
type. However, the existence of host regulatory mechanisms that prevent and protect from an
excessive immune response can not be excluded. In fact, no increase in liver immunopathol-
ogy is detected in P25 mice, in comparison with WT mice.
As previously referred, the P25 mice used in this study are in a RAG-sufficient background.
In this condition, the presence of CD4+ T cells that are not specific for Ag85 (which compose
less than 15% of the CD4+ T cell compartment) could be eliciting most of the immune
response to the bacteria. Against this, we observe an expansion of Ag85-specific CD4+ T cells
with infection, alterations on the T cell activation profile that are more exuberant in the trans-
genic over the non-transgenic cells and more IFNγ+ and TNF+ CD4+ T cells in the transgenic
compartment. All together, these results suggest that the immune response in the P25 mice is
mostly driven by P25 transgenic CD4+ T cells, and that this highly skewed repertoire is as pro-
tective as a diverse one. Extremely skewed repertoires have been shown to be protective in the
context of several viral infections. However, in the case of viruses highly prone to mutations
this restricted immune response to immunodominant epitopes might be detrimental as it
becomes evaded upon mutation [33]. Both in humans and in mouse models, a clonal expan-
sion, mostly of CD8+ T cells, during M. tuberculosis infection arises and, in the specific case of
C57BL/6 mice, 30 to 50% of the CD8+ T cells recognise a single epitope upon infection [34–
36]; prominent TCR clonal expansions have been associated with more severe tuberculosis
cases [37,38]. However, these reports could not clearly demonstrate whether the strongly
skewed repertoire was the cause of disease severity or vice-versa, a subject that remains to be
explored.
Collectively, our results suggest that an immune response dominated towards Ag85 is
sufficient to promote long-term protection to M. avium. Importantly, despite the prevalent
response mediated by P25 transgenic T cells, no increased immunopathology is detected. This
information may be of relevance for the antigen-based vaccine strategies.
Supporting information
S1 Fig. Flow cytometry gating strategies. A) Representative gating strategy used to
identify naive (CD62L+CD44lo/int), activated (CD62L-CD44int/hi) and central memory
(CD62L+CD44int/hi) CD4+ T cells. B) Representative gating strategy used to identify IFN, IL2
and TNF producing CD4+ T cells.
(EPS)
S2 Fig. Unlike P25 mice, Limited mice, which also harbor a restricted TCR repertoire, are
unable to control Mycobacterium avium infection. Quantification of spleen (left) and liver
(right) colony forming units (CFUs) from WT (Exp#3), P25 (Exp#1), TCRα KO (Exp#2 and 3)
and Limited mice (Exp#2 and 3) with 24 to 27 weeks post-infection (dpi). No significant differ-
ences were observed on Exp#2 by Student t-test. p< 0.001 by one-way ANOVA test and
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followed by Bonferroni post-hoc tests (Exp#3). Each symbol represents one mouse and the
line the mean.
(JPG)
S3 Fig. TCR staining as an adequate surrogate marker for transgenic CD4+ T cells in P25
mice. A) Representative FACS plot of the different CD4+ T cells sub- populations according to
the expression of VαMix(2, 3, 8 and 11) and Vβ11 (left). B) Percentage of Ag85B240-254-specific
(Tetramer+) CD4+ T cells among each of four sub-populations based on VαMix and Vβ11
staining. C) Percentage of Tetramer+ cells on each of four sub-populations based on VαMix
and Vβ11 staining within CD4+ T cells. p< 0.001 by one-way ANOVA test followed by
Bonferroni post-hoc test. Each symbol represents one mouse, the line the mean; data represen-
tative of two independent experiments. Tetramer stain did not compromise TCR stain, since
single (tetramer stain only) or multiple (tetramer stain followed by Vβ11 and VαMix stain) ren-
dered similar Vβ11+Vα- percentages (84.3±2.9 vs. 85.1±2.1, p = 0.8945).
(EPS)
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